Xigris Infusion

Drotrecogin alfa
20mg
LILLY PHARMA FERTIGUNG UND DISTRIBUTION, GmbH & CO.
Pack size 1 Vial (Dry)
Dispensing mode POM
Source GERMANY
AgentPHARMATRADE
Retail Price 3916.50 AED

Available as:

Indications

Xigris Infusion is used for: For reduction of mortality in patients with severe sepsis.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Drotrecogin alfa :

Mechanism of Action

Activated protein C combines with protein S on platelet surfaces and then degrades factor Va and factor VIIIa, thereby reducing blood coagulability.

Note

Xigris 20mg Infusion manufactured by LILLY PHARMA FERTIGUNG UND DISTRIBUTION, GmbH & CO.. Its generic name is Drotrecogin alfa. Xigris is availble in United Arab Emirates. Farmaco UAE drug index information on Xigris Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Drotrecogin alfa :